Reverse transcriptase-polymerase chain reaction assays for prostate cancer

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 367-378

  Olsson, C A ^a   De Vries, G M ^a   Buttyan, R ^a   Katz, A E ^a  

^a Atchley Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

BLOOD; BONE MARROW METASTASIS; CANCER STAGING; HUMAN; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SAMPLING;

EID: 0030966777     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70383-9     Document Type: Article

References (80)

1. S. Aznavoorian A.N. Murphy W.G. Stetler-Stevenson Molecular aspects of tumor cell invasion and metastasis Cancer 71 1993 1368
2. O.V. Batson The function of the vertebral veins and their role in the spread of metastasis Ann Surg 112 1940 138
3. M.C. Benson G.M. de Vries A.E. Katz Enhanced RT-PCR for PSA offers unique prognostic information during androgen deprivation therapy J Urol 155 1996 437A
4. R. Bichi G. Martinazzo L.G. Gomella C-TRAK detection of RT-PCR products in prostate cancer molecular staging J Urol 155 1996 553A
5. C.L. Cama C.A. Olsson R.E. Buttyan Molecular staging of prostate cancer III: Effects of digital rectal examination, cystoscopy, and needle biopsy on the enhanced reverse transcriptase-polymerase chain reaction assay J Urol 155 1996 553A
6. J. Clements A. Mukhtar Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium J Clin Endocrinol Metab 78 1994 1536
7. E. Cline F. Vanky U. Galili Separation and characteristics of tumor infiltrating lymphocytes in man Witz I.P. Hana M.D. Contemporary Topics in Immunobiology ed 10 1980 Plenum New York 79
8. T. Deguchi T. Doi H. Ehara Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction Cancer Res 53 1993 5350
9. G.M. de Vries C.A. Olsson M.C. Benson Quantitative and qualitative RT-PCR for PSA: Molecular staging of prostate cancer J Urol 155 1996 417A
10. E.P. Diamandis H. Yu D.J. Southerland Detection of prostate specific antigen immunoreactivity in breast tumors Breast Cancer Res Treat 32 1994 301
11. C.W. Dieffenbach T.M. Lowe G.S. Dveksler General concepts for PCR primer design PCR methods appl 3 1993 S30
12. P.R. Dodds V.J. Caride B. Lytton The role of vertebral veins in the dissemination of prostate cancer J Urol 126 1981 753
13. Y.H. Dotta P.T. Adams W.R. Drobyski Sensitive detection of occult breast cancer by the reverse transcriptase-polymerase chain reaction J Clin Onc 12 1994 475
14. F. Dumas P. Eschwege P. Blanchet Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma using prostate specific membrane antigen (PSM)-based nested reverse transcription polymerase chain reaction assay J Urol 155 1996 506A
15. R.A. Edelstein R.J. Crane R.K. Babayan A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcriptase-polymerase chain reaction assay Urology 45 1995 597
16. Edelstein RA, Zietman AL, de las Morenas A, et al: Implication of prostatic micrometastases to the pelvic lymph nodes: First report of an archival tissue gene expression study. J Urol 155:50S
17. D.W. Ellis S. Leffers J.S. Davies Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate Am J Clin Pathol 81 1984 279
18. W.J. Ellis R.L. Vessella E. Corey Use of a reverse transcriptase polymerase chain reaction (RT-PCR) to detect prostate cancer cells in the blood J Urol 155 1996 378A
19. P. Eschwege F. Dumas P. Blanchet Hematogenous dissemination of prostatic epithelial cells during radical prostatectomy Lancet 346 1995 1528
20. P. Eschwege F. Dumas P. Blanchet Hematogenous prostatic epithelial cells microdissemination during radical prostatectomy J Urol 155 1996 528A
21. M.F. Fey A.E. Kulozik T.E. Hansen-Hagge The polymerase chain reaction: A new tool for the detection of minimal residual disease in hematologic malignancies Eur J Cancer 27 1991 89
22. X. Gao D.J. Gringon T. Chbihi Elevated 120 lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer Urology 46 1995 227
23. R.A. Ghossein H.I. Scher W.L. Gerald Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: Clinical implications J Clin Oncol 13 1995 1195
24. G.D. Hall C.E. Kramer J.I. Epstein Evaluation of radical prostatectomy specimens: A comparative analysis of sampling methods Am J Surg Pathol 16 1992 315
25. F.C. Hamdy J. Lawry J.B. Anderson Circulating prostate specific antigen cells correlate with metastatic prostate cancer Br J Urol 69 1992 392
26. P. Henttu P. Vihko cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes Biochem Biophys Res Comm 160 1989 903
27. H. Hircak G.C. Dooms R.B. Jeffery Prostatic carcinoma: Staging and clinical assessment, CT, and MR imaging Radiology 162 1987 331
28. R.S. Israeli W.H. Miller S.L. Su Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays Cancer Res 54 1994 6306
29. R.S. Israeli C.T. Powell W.R. Fair Molecular cloning of a complimentary DNA encoding a prostate-specific membrane antigen Cancer Res 53 1993 227
30. S. Jaakkola T. Vornanen J. Leinonen Detection of prostatic cells in peripheral blood: Correlation with serum concentrations of prostate-specific antigen Clin Chem 41 1995 182
31. A.E. Katz G.M. de Vries M.D. Begg Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer Cancer 75 1995 1642
32. A.E. Katz G.M. de Vries C.A. Olsson Molecular staging of genitourinary malignancies Urology 47 1996 948
33. A.E. Katz C.A. Olsson A.J. Raffo Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay Urology 43 1994 765
34. M.S. Lee K.S. Chang F. Cabanillas Detection of minimal residual cells carrying the t(14:18) by DNA sequence amplification Science 237 1988 175
35. L.A. Mattano Jr T.J. Moss S.G. Emerson Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction Cancer Res 52 1992 4701
36. S.W. Melchior E. Corey W.J. Ellis Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate (CAP) J Urol 155 1996 554A
37. M. Miyomura Y. Tanimoto K. Morishima Detection of philadelphia chromosome-positive acute lymphoblastic leukemias by polymerase chain reaction: Possible eradication of minimal residual disease by marrow transplantation Blood 79 1992 1366
38. M. Monne C.M. Croce H. Yu Molecular characterization of prostate specific antigen messenger RNA expressed in breast tumors Cancer Res 54 1994 6344
39. J.G. Moreno C.M. Croce R. Fischer Detection of hematogenous micrometastasis in patients with prostate cancer Cancer Res 52 1992 6110
40. J.G. Moreno J.P. Long M. O'Hara Surgical prostatic instrumentation causes showering of prostate cells into the circulation as determined by RT-PCR of PSA J Urol 155 1996 553A
41. J.G. Moreno P.J. Shenot D. Shupp-Byrne Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate-specific antigen Techniques in Urology 2 1996 54
42. T.J. Moss D.G. Sanders Detection of neuroblastoma cells in blood J Clin Oncol 8 1990 736
43. G. Murphy H. Raagde G. Kenny Comparison of prostate-specific membrane antigen and prostate-specific antigen levels in prostate cancer patients Anticancer Res 15 1995 1473
44. H. Naito N. Kuzumaki J. Uchino Detection of tyrosine hydroxylase mRNA and minimal neorublastoma cells by the reverse transcription-polymerase chain reaction Eur J Cancer 27 1991 762
45. M.G. Oefelein B. Herz J.M. Ignatoff Longitudinal assessment by prostate specific antigen (PSA) reverse transcriptase-polymerase chain reaction (RT-PCR) of circulating prostate epithelial cells following radical prostatectomy (RRP) J Urol 155 1996 552A
46. M.G. Oefelein K. Kaul B. Herz Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy J Urol 155 1996 238
47. S.M. O'Hara R.W. Veltri P. Skipstuas Basal PSA mRNA levels detected by quantitative reverse transcriptase-polymerase chain reaction (Q-RT-PCR-PSA) in blood from subjects without prostate cancer J Urol 155 1996 418A
48. C.A. Olsson G.M. de Vries A.J. Raffo Preoperative reverse transcriptase-polymerase chain reaction for prostate-specific antigen predicts treatment failure following radical prostatectomy J Urol 155 1996 1557
49. C.A. Olsson E.T. Goluboff Detection and treatment of prostate cancer: Perspective of the urologist J Urol 152 1994 1695
50. S.L. Parker T.M. Tong S. Bolden Cancer statistics CA Cancer J Clin 46 1996 5
51. O.P. Paul G. Ts'o S. Bova Harvest of circulating prostate cancer cells for customized decision making, monitoring and treatment of advanced prostate cancer J Urol 155 1996 607A
52. Pilarsky CP, Richter AE, Kranz R, et al: Clinical significance of the determination of prostate cells in blood by RT-PCR of prostate specific oncogene PTI-1. Presented at European Association of Urology meeting, September 1996.
53. Rubin MA, Fang M, Stifelman MD, et al: Enhanced reverse transcriptase-PCR for prostate specific antigen combined with needle biopsy results: A strong indicator of extraprostatic disease. Submitted
54. J.O. Salo L. Kivisaari S. Rannikko Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic carcinoma before radical retropubic prostatectomy J Urol 137 1987 435
55. R. Scaletscky M.O. Koch C.W. Eckstein Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen J Urol 152 1994 129
56. M.V. Seiden P.W. Kantoff K. Krithivas Detection of circulating tumor cells in men with localized prostate cancer J Clin Oncol 12 1994 2634
57. G.F. Sensabaugh Isolation and characterization of a semen specific protein from human seminal plasma: A potential new marker for semen identification J Forensic Sci 23 1978 106
58. R. Shen Z.Z. Su C.A. Olsson Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display PNAS 92 1995 6778
59. K.M. Slawin S.M. O'Hara W. Song Comparison of results obtained using different RT-PCR-PSA assay methods on a single set of clinical specimens J Urol 155 1996 417A
60. B. Smith P. Selby J. Southgate Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction Lancet 338 1991 1227
61. M.R. Smith S. Biggar M. Hussein Prostate-specific antigen messenger RNA is expressed in non-prostate cells: Implications for detection of micrometastases Cancer Res 55 1995 2640
62. M.H. Sokoloff T. Cho-Lea R. Kaboo Quantitative polymerase chain reaction does not improve prostate cancer staging: A clinical-pathologic-molecular analysis of 121 patients J Urol 155 1996 417A
63. M.H. Sokoloff A. Patel T. Cho-Lea Surgical manipulation does not result in hematogenous dissemination of prostate cancer [PC] cells J Urol 155 1996 528A
64. T. Takahashi S. Hoshi S. Orikasa Genetic diagnosis of pelvic lymph node metastasis in prostate cancer J Urol 155 1996 378A
65. B. Tycko J.D. Palmer M.P. Link Polymerase chain reaction amplification of rearranged antigen receptor genes using junction-specific oligonucleotides: Possible application for detection of minimal residual disease in acute lymphoblastic leukemia Cancer Cells 7 1989 47
66. R.L. Vessella K.A. Blouke J.E. Stray The use of the polymerase chain reaction to detect metastatic prostate cancer in lymph nodes and bone marrow Proceedings of the American Association for Cancer Research 33 1992 2367
67. G.E. Voges J.E. McNeal E.A. Redwine Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinomas of the prostate Cancer 69 1992 520
68. M.C. Wang L.D. Papsidero M. Kuriyama Prostate antigen: A marker for human prostate epithelias cells Prostate 2 1981 89
69. M.C. Wang L.A. Valenzuela G.P. Murphy Purification of a human prostate specific antigen Investig Urol (Berl) 17 1979 159
70. S. Warren P.N. Harris R.C. Graves Osseous metastasis of prostate cancer Archives of Pathology 22 1936 139
71. D.P. Wood The molecular staging of prostate cancer Semin Urol 13 1995 96
72. D.P. Wood E.R. Banks S. Humphries Identification of bone marrow micrometastases in patients with prostate cancer Cancer Res 74 1994 2533
73. D.P. Wood E.R. Banks S. Humphries Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow J Histochem Cytochem 42 1994 505
74. D.P. Wood S. Humphries V.M. Rangnekar Effect of hormonal therapy on circulating prostate cells J Urol 155 1996 553A
75. D.P. Wood M. Weinstien S. Humphries Prognostic significance of circulating prostate cells J Urol 155 1996 418A
76. G.L. Wright B.M. Grob P.F. Schellhammer Prostate specific membrane antigen (PSMA) is upregulated following hormone-deprivation therapy J Urol 155 1996 692A
77. J.W. Xuan J.L. Chin A.F. Chambers Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue Oncogene 11 1995 1041
78. C.Y. Young P.E. Andrews D.J. Tindall Expression and androgenic regulation of human prostate-specific kallikreins J Androl 16 1995 97
79. H. Yu E.P. Diamandis M. Lavesque Expression of the prostate specific antigen gene by a primary ovarian carcinoma Cancer Res 55 1995 1603
80. B.R. Zetter The cellular basis of site-specific metastasis N Engl J Med 322 1990 605